People: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

61.46USD
26 Feb 2015
Change (% chg)

$0.24 (+0.39%)
Prev Close
$61.22
Open
$61.19
Day's High
$61.60
Day's Low
$60.75
Volume
1,192,013
Avg. Vol
1,798,496
52-wk High
$64.44
52-wk Low
$46.32

Search Stocks

Caforio, Giovanni 

Brief Biography

Dr. Giovanni Caforio M.D., has been Chief Executive Officer, Director of Bristol-Myers Squibb Company effective May 5, 2015. He has served as Chief Operating Officer, Director of the company effective May 5, 2015. He brings a broad range of experience to his role as chief operating officer. He joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, and assumed leadership roles for Greece, South East Europe, and in 2004, was appointed senior vice president, European Marketing and Brand Commercialization. From 2007 to 2011, Caforio helped build the company’s leadership in immuno-oncology while directing U.S. and Global oncology, and made valuable contributions to the company’s strategic focus and operational performance in roles as U.S. president and chief commercial officer from 2011 to 2014. Prior to joining Bristol-Myers Squibb, Caforio spent 12 years with Abbott Laboratories in a number of leadership positions. Caforio earned his M.D. from the University of Rome prior to joining the pharmaceutical industry.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,536,880 -- 177,861 3,301,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Cornelius

10,859,000

Charles Bancroft

7,878,020

Louis Schmukler

--

Giovanni Caforio

3,301,850

Francis Cuss

3,719,040

Paul von Autenried

--
As Of 30 Dec 2013
Search Stocks